Asherman Syndrome. Intrauterine Synechiae
Conditions
Interventions
Intervention 1: Adhesion release and
hyaluronic gel injection
genewel company (10cc=5gr)
commercial name =Guardix. Intervention 2: Adhesion release without gel injected.
Treatment - Surgery
Adhesion release and
hyaluronic gel injection
genewel company (10cc=5gr)
commercial name =Guardix
Adhesion release without gel injected
Sponsors
Shahid Beheshti Medical School
Eligibility
Sex/Gender
Female
Age
18 Years to 46 Years
Inclusion criteria
Inclusion criteria: Including criteria: intrauterine adhesion according to 3D sonography; sonohysterography; hysterosalpingography; hysteroscopy. Excluding criteria: unsatisfaction; age more than 50; weight more than 100 kg; menopause; pregnancy; malignancy; coagulopathy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adhesion scoring. Timepoint: 4 to 6 weeks after hysteroscopy. Method of measurement: With hysteroscopy & ASRM score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy Rate. Timepoint: After action for pregnancy. Method of measurement: B HCG. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHatav Ghasemi Tehrani
Isfahan Medical School
Outcome results
None listed